Skip to main content

Featured

Grocery Benefit Pays Monday, Oct. 5: What You'll Actually Get — and Who Gets $0

  The second Canada Groceries and Essentials Benefit (CGEB) payment lands Monday, Oct. 5, and it's the last one of 2026. Some households will see $222.50. Others will see nothing. Here's how to tell which group you're in. At a glance Payment date: Monday, Oct. 5, 2026 (tax-free) Maximum per payment: $169.75 single, $222.50 couple, plus $58.50 per child under 19 Based on: your 2025 tax return Next payments: January and April 2027 Check which number you're reading: yearly or per payment A lot of coverage this week quotes $679 for singles and $890 for couples. Those are the yearly maximums for the July 2026 to June 2027 benefit year, paid in four quarterly instalments. What arrives Monday is one quarter of that. Household Max per year Max per payment Single, no children $679 $169.75 Married or common-law $890 $222.50 Each child under 19 (added on) $234 $58.50 First child in a single-parent family $445 $111.25 Most households get less than the maximum The CGEB is incom...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment